PGC associated_with ADHD
Evidence from:
primary |
all sources
Evidence (6 sources)
Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder.
(2019)
PMID:30478444
cited
Summary statistics with the results from the ADHD GWAs meta-analysis of iPSYCH and the PGC samples are available on the PGC website.
confidence: 0.95
Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder.
(2019)
PMID:30478444
cited
11 European, North American and Chinese cohorts aggregated by the Psychiatric Genomics Consortium (PGC)
confidence: 0.92
The group is now working on bipolar disorder, ADHD, and PTSD.
confidence: 0.90
A mega-analysis of genome-wide association studies for major depressive disorder.
(2013)
PMID:22472876
cited
The PGC is conducting GWAS metaanalyses across ADHD, autism, BIP, MDD and schizophrenia.
confidence: 0.90
PGC began ... investigators who had GWAS funded for Attention Deficit Hyperactivity Disorder (ADHD)
confidence: 0.96
The results are meant to inform research into ADHD.
confidence: 0.90